NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/08/2024
Back to search
Official data from USPTO
AIM WITH IMMUNOTHERAPY FOUNDATION IMMUNO-ONCOLOGY ESSENTIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/08/2024
Trademark type
Combined
Nice classes
9, 41, 42, 44
Filing date
07/06/2023
Registration date
10/08/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/08/2024
Last transaction
10/08/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/07/2018
First use in commerce
12/07/2018
Drawing code
3
Owner type
99
Owner location
Sacramento, CA
Examiner
AWRICH, ELLEN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "AIM" with a dot above the "I", above the words "WITH IMMUNOTHERAPY" above a horizontal line, with the word "FOUNDATION" below the line, all in a stylized font and to the left of a vertical line. To the right of the vertical line, the word "IMMUNO-" is above the word "ONCOLOGY" above the word "ESSENTIALS", all in a stylized font.
Holders and representatives
Holders
A. I. (pessoa física)
Representatives
Eugene M. Pak FENNEMORE WENDEL
Technical classification
Nice Classes
Class 9Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable booksmagazinesnewslettersvideos and articles in the field of cancercancer researchimmune-related medical conditions and immune-related therapies
Class 41
Educational servicesproviding on-line non-downloadable webinars and videos in the field of cancercancer researchimmune-related medical conditions and immune-related therapies
Class 42
Providing medical and scientific research information in the field of cancercancer researchimmune-related medical conditions and immune-related therapies; Providing on-line medical and scientific research information in the field of cancercancer researchimmune-related medical conditions and immune-related therapies; Providing a website featuring medical and scientific research information in the field of cancercancer researchimmune-related medical conditions and immune-related therapies; Providing a website featuring technology to facilitate peer-to-peer mentoring among cancer practitionersresearchers and patients
Class 44
Providing health information in the field of cancercancer researchimmune-related medical conditionsimmune-related therapies; Providing on-line health information in the field of cancercancer researchimmune-related medical conditionsimmune-related therapies; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing a website featuring health information in the field of cancercancer researchimmune-related medical conditionsimmune-related therapies
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2024
PUBO
PUBLISHED FOR OPPOSITION
07/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/14/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/14/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/14/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/18/2024
GNRT
NON-FINAL ACTION E-MAILED
03/18/2024
CNRT
NON-FINAL ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
03/18/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2023
NWAP
NEW APPLICATION ENTERED
07/10/2023
Continuous trademark protection
Get notified about every new filing that threatens AIM WITH IMMUNOTHERAPY FOUNDATION IMMUNO-ONCOLOGY ESSENTIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.